ROUND CELL LIPOSARCOMA
Clinical trials for ROUND CELL LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ROUND CELL LIPOSARCOMA trials appear
Sign up with your email to follow new studies for ROUND CELL LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to halt rare cancer growth
Disease control Recruiting nowThis study tests whether two drugs, mirdametinib and palbociclib, can safely control advanced liposarcoma that has spread or cannot be removed by surgery. About 54 adults with this rare cancer will receive different doses to find the best balance of safety and effectiveness. The …
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Experimental drug aims to revive failing cancer fighters in rare sarcomas
Disease control Recruiting nowThis early study tests a drug called N-803 in 8 people with rare soft-tissue sarcomas (synovial sarcoma or myxoid/round cell liposarcoma) whose cancer grew after a prior cell therapy. N-803 is an immune-boosting protein that may help the body's remaining cancer-fighting cells wor…
Matched conditions: ROUND CELL LIPOSARCOMA
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC